Reuters - Quadrant-backed Virtus Health Launches Australia IPO
Virtus Health, an in-vitro fertilization business backed by Australian buyout firm Quadrant Private Equity, launched an up to $300 million initial public offering, writes Reuters. The offering for Virtus Health, the largest IVF group in the Asia-Pacific region, is for 51.3 million to 53.7 million shares in an indicative range of A$4.92-5.68, added IFR, a Thomson Reuters publication.
29 April 2013•1 min read
